On April 4, the bio regenerative medicine manufacturer CGBio (CEO Hyun Seung Yu) revealed that the company has participated in the anti-aging academic conference ‘Aesthetic and anti-aging Medicine World Congress (AMWC) 2023’ held at Monte Carlo from March 30 to April 1.

AMWC is the world’s largest plastic surgery and beauty clinic academic conference and exhibition visited by over 10,000 people from all over the world every year. With major companies from approximately 120 countries participating in the event and unveiling their latest products and technologies, CGBio has opened an independent booth at this conference and unveiled its flagship cosmetic surgery products.

CGBio has garnered significant interest from the visitors as it unveiled cosmetic surgery total solution products developed based on the company’s regenerative medicine technology including the hyaluronic acid (HA) filler Aileene, calcium hydroxyapatite (CaHA) filler Facetem, SVF full-auto extractor CELLUNIT, breast massager BELUNA, microneedle patch DERMAREGEN, and lifting thread EXOFT.

At this exhibition, CGBio has conducted meetings with dealerships from various countries for business discussions and Q&A sessions, and the company explains that it has confirmed the possibility of expanding into Monaco and the rest of the cosmetic surgery market in Europe through these interactions.

Furthermore, CGBio has also reached and concluded the supplier agreement for calcium filler ‘Facetem’ worth 12 billion won over 3 years and 45 billion won over 3 years respectively with Argentina and France during the exhibition period. Also, there is an ongoing positive discussion between the CEOs of the two companies regarding the business of supplying Facetem fillers to dealerships in Ecuador and Kazakhstan as the possibility of reaching future agreements has become more likely.

Booth visitors showed significant interest in the new lifting thread product ‘EXOFT’ first unveiled in Europe along with the other aesthetic product lines from CGBio. EXOFT offers two lineups consisting of a cog thread made of 360-degree press-cutting Polydionanone(PDO) material with strong face lifting stability made with the patented cog technology of CGBio, and a cog thread made of Polycaprolactone(PLCL) material that is natural and offers long-term durability as the product offers competitiveness that is differentiated from other lifting threads in the market.

CGBio is looking to expand its aesthetic business and establish a foothold as a global aesthetic supplier by actively targeting markets overseas starting with Europe through this event.

CEO of CGBio Hyun Seung Yu stated, “We are pleased to introduce superb cosmetic surgery products from Korea developed with independent technology of CGBio at AMWC and to receive positive response from other participants” and continued, “We took our first step for expanding into markets overseas through the export agreement for GISELLELIGNE in China and as we continue to actively target markets overseas, we are planning to further increase our global business activities in the future.”

He also added, “CGBio intends to continue to develop products based on regenerative medicine technology and we will not just stop at developing and launching products, but also conduct training for the medical staff for our products to be used correctly on the patients as we continue to target the global market while also contributing to improving the health of patients.”

CGBio is the only company in Korea that owns the three elements of regenerative medicine (cells, supporters, and growth factors), and it is actively expanding its product portfolio even into the anti-aging market based on its regenerative medicine technology know-hows. The company is especially focusing on expanding into the global aesthetic market with high growth potential, and participated in Dubai Derma 2023 held in Dubai earlier this month, where the company has concluded a filler distribution agreement worth 1.8 billion won over 3 years with dealerships in the three Baltic countries and finalized the filler orders worth 730 million won with dealerships in Brazil during the exhibition period.

▲ CGBio Participating in the Global Beauty and Anti-aging Academic Conference ‘AMWC’ and Concludes a Supplier Agreement for Calcium Filler ‘Facetem’ Worth 16.5 Billion Won